Robert Matthews, MD- Publications

ARTICLES

  • Matthews R, Franceschi D, and Cabahug C. “Abdominal Muscle Uptake on FDG PET Secondary to Multiple Rib Fractures and Use of Accessory Muscles of Respiration.” Clin Nucl Med 2005;30:333-34.
  • Matthews R. “Before the Fallout: From Marie Curie to Hiroshima.” J Nucl Med 2006;47:896.
  • Matthews R. “Voices from Chernobyl: The Oral History of a Nuclear Disaster.” J Nucl Med 2006;47: 1389-90.
  • Matthews R. “Classic Feynman: All the Adventures of a Curious Character.” J Nucl Med 2006;47:1391-92.
  • Matthews R and Relan N. “Quantitation in Biomedical Imaging with PET and MRI.” J Nucl Med.2006;47:1728-29.
  • Matthews R. “Contact Wounds: A War Surgeon’s Education.” J Nucl Med 2006;47:2066-67.
  • Matthews R, Franceschi D, Wenlang X, Cabahug C, Schuman G, Bernstein R, and Peyster R. “Parietal Lobe Epileptic Focus Identified on SPECT-MRI Fusion Imaging in a Case of Epilepsia Partialis Continua.” Clin Nucl Med. 2006;31:826-828.
  • Matthews R and Relan N. “CT Teaching Manual: A Systemic Approach to CT Reading.” J Nucl Med 2007;48:494.
  • Matthews R. “The Curies: A Biography of the Most Controversial Family in Science.” J Nucl Med 2007;48:1224.
  • Matthews R and Matthews R. “Every Second Counts: The Race to Transplant the First Human Heart.” J Nucl Med 2007;48:1571-72.
  • Matthews R. “Beyond Knowing: Mysteries and Messages of Death and Life from a Forensic Pathologist.” J Nucl Med 2007;48:1749.
  • Matthews R and Relan N. “Advances in Healthcare Technology: Shaping the Future of Medical Care.” J Nucl Med 2008;49:336.
  • Matthews R and Matthews R. “Health Care Meltdown: Confronting the Myths and Fixing Our Failing System.” J Nucl Med 2008;49:1564-55.
  • Matthews R. “Hooked: Ethics, the Medical Profession, and the Pharmaceutical Industry.” J Nucl Med 2008;49:2068-69.
  • Matthews R, Kudelka A, and Kaloudis E. “Visual Vignette. Metastatic Neuroendocrine Tumor.” Endocrine Practice 2008;14:1065.
  • Shrestha P and Matthews R. “Radiologic Clinics: Imaging of Lymphoma.” J Nucl Med. 2009;50:1740-41.
  • Goodman M and Matthews R. “The Road to Yucca Mountain: The Development of Radioactive Waste Policy in the United States.” J Nucl Med. 2010;51:819-20.
  • Matthews R, Shrestha P, Franceschi D, Relan N, and Kaloudis E. “Head and Neck Cancers: Post-Therapy Changes in Muscles with FDG PET-CT.” Clin Nucl Med. 2010;35:494-498.
  • Kim HR and Matthews R. “Safe Patients, Smart Hospitals: How One Doctor’s Checklist Can Help Us Change Health Care from the Inside Out.” J Nucl Med 2010;52:162-163.
  • Carcamo CJ and Matthews R. “The Fever: How Malaria has Ruled Humankind for 500,000 Years.” J Nucl Med. 2012;53:343-344.
  • Franceschi AM and Matthews R. “Diagnostic Imaging. Musculoskeletal: Non-Traumatic Disease.” J Nucl Med. 2012;53:658-659.
  • Franceschi AM, Matthews R, Mankes S, Safaie E, and Franceschi D. “Four Chamber FDG Uptake in the Heart: An Indirect Sign of Pulmonary Embolism.” Clin Nucl Med. 2012;37:687-91.
  • Matthews R, Bench T, Meng H, Franceschi D, Relan N, and Brown DL. “Diagnosis and Monitoring of Cardiac Sarcoidosis with Delayed-Enhanced MRI and 18F-FDG PET-CT.” J Nucl Cardiol. 2012;19:807-810.
  • Goldberg M, Matthews R, Meng H, Bilfinger T, and Kort S. “Evaluation of Cardiac Involvement with Mediastinal Lymphoma: The Role of Innovative Integrated Cardiovascular Imaging” Echocardiography 2012;29:E189-92.
  • Matthews R, Schuster M, Safaie E, Relan N, and Franceschi D. “Fluorodeoxyglucose PET-CT Findings Following Bone Marrow Harvesting.” World J Nucl Med. 2012;11:19-21.
  • Moore W, Freiberg E, Bishawi M, Halbriener M, Matthews R, Bilfinger T, and Baram D. “FDG-PET Imaging in Patients with Carcinoid Tumor of the Lung.” Clin Nucl Med. 2013;38:501-5.
  • Matthews R, Goodman M, Relan, P, Safaie E, and Franceschi D. Tc-99m Mebrofenin Hepatobiliary Scan in Obstructive Hepatobiliary Disease: Determining Causes with Early and Late Delayed Imaging. World J Nucl Med 2013. Accepted for publication.
  • Vu CC, Matthews R, Kim B, Franceschi D, Bilfinger TV, and Moore WH. “Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis from 18F-FDG PET/CT in Patients Undergoing Stereotactic Body Radiation Therapy for Stage I Non-Small-Cell Lung Cancer.” Nucl Med Comm 2013. Accepted for publication.

ABSTRACTS

  • Matthews R, Youssef IM, Bukala K, Quispe M, Kim CK, Krynyckyi BR, and Machac J. “Reproducibility of Coronary Flow Reserve (CFR) Measurements with Rubidium-82 PET Perfusion Imaging.” Clin Nucl Med 2005;30:373.
  • Youssef IM, Travis AR, Matthews R, Almeida O, Krynycki BR, Kim CK, and Machac J. “Localization of Disease in Patients with Coronary Artery Disease with Rubidium-82 Stress and Rest PET Myocardial Perfusion Imaging.” Society of Nuclear Medicine, 52rd Annual Meeting, Toronto, June 2005. No. 885. Selected by Dr. Wagner in Highlights Lecture at end of meeting.
  • Machac J, Matthews R, Almeida O, Youssef IM, Krynyckyi BR, Kim CK, Padilla M, Iannuzzi M, and Teirstein A. “Characterization of Patients at Risk of Cardiac Sarcoidosis with PET Stress and Rest Rubidium-82 and F-18 Fluorodeoxyglucose Imaging.” Society of Nuclear Medicine, 52rd Annual Meeting, Toronto, June 2005. No. 890.
  • Youssef IM, Colon D, Rafique A, Sata S, Kim CK, Krynycki BR, Matthews R, and Machac J. “The Benefit of Two CT Transmission Scans for Rubidium-82 Cardiac PET Myocardial Perfusion Imaging.” Abstract and Presentation. Society of Nuclear Medicine, 52rd Annual Meeting, Toronto, June 2005. No. 331.
  • Schachter M, Connors P, Mathew J, Naik M, Girard C, Matthews R, and Stanley W. “Benefits of  SPECT and PET Fusion with Anatomical Modalities.” Abstract and Presentation. Technologist Section, Greater New York Chapter, Society of Nuclear Medicine, 35th Annual Meeting, Atlantic City, March 2006, 2nd Prize
  • Winner.  
  • Franceschi D, Relan N, Cabahug C, and Matthews R. “Bone Marrow FDG Uptake in Patients with Extensive Neoplastic Disease at Initial Presentation.”  Abstract and Presentation. Annual Congress of the European Association of Nuclear Medicine, Athens, Greece, October 2006. Euro J Nucl. 2006;33(9):S153
  • Franceschi D, Matthews R, Cabahug C, and Relan N. “Incidental Foci of Colonic FDG Uptake in Most Cases Represent Premalignant Adenomas.” 9th Congress of the World Federation of Nuclear Medicine and Biology. Oct 2006, Seoul, South Korea. Wold J Nucl Med 2006;5(1):S91.
  • Franceschi D, Relan N, Cabahug C, and Matthews R. “Significance of Bone Marrow FDG Uptake in Patients with Extensive Neoplastic Disease.”, 9th Congress of the World Federation of Nuclear Medicine and Biology. Oct 2006, Seoul, South Korea. World J Nucl Med 2006;5(1):S90.
  • Bevilacqua J, Guevara J, Weiss J, Matthews R, Relan N, Stanley W, Franceschi D, and Cabahug C. “Evaluation of Co-registration in Molecular Imaging: PET-PET Fusion.” Abstract and Presentation. Technologist Section, Greater New York Chapter, Society of Nuclear Medicine, 36th Annual Meeting, Atlantic City, March 2007, 2nd Prize Winner.  
  • Matthews R, Relan N, Franceschi D, and Cabahug C. “Follow Up Malignancies Using Integrated Whole-Body PET Fusion and Subtraction Techniques.” Abstract. Joint Molecular Imaging Conference, Rhode Island, September 2007. No. 684.
  • Franceschi D, Matthews R, Relan N, Weiss J, and Cabahug C. “Post Radiation Liver Inflammation on FDG PET/CT in Patients Treated for Distal Esophageal Cancer.” Poster Session. EANM’08 – Annual Congress of the European Association of Nuclear Medicine, Munich, Germany, October 2008. Euro J Nucl Med 2008;35(Suppl 2):S273.
  • Relan N, Matthews R, Franceschi D, and Cabahug C. “PET-CT Imaging: Factors Affecting Quantification in PET-CT Imaging.” International Conference on Medical Physics, Radiation Protection and Radiobiology (ICMPRPR 2K9), Jaipur, India, January 2009.
  • Goodman M, Matthews R, Relan N, Safaie E, and Franceschi D. “Role of Delayed Tc-99m Mebrofenin Scanning in Evaluating Obstructive Hepatobiliary Disease.” Society of Nuclear Medicine 57th Annual Meeting, Salt Lake City, Utah, June 5-9, 2010. J Nucl Med 2010;51(Supplement 2):1584.
  • Franceschi D, Matthews R, Relan N, and Safaie E. “Increased FDG Uptake by the Bone Marrow in Some Patients with Newly Diagnosed Cancer.” World J Nucl Med. 2010;9:S153.
  • Relan N, Matthews R, and Franceschi D. “Regulatory Issues in Investigational Radiopharmaceuticals for Drug Development in the United States.” 1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy (PRRNT), Zentralklinik Bad Berka, Germany, June 23-26, 2011.
  • Moore W, Matthews R, Hovnanian M, Weir J, Santos T, and Bilfinger T. “FDG-PET Imaging Findings Post Cryoablation of Patients with Primary Stage 1 Lung Cancer.” Scientific Formal Presentation, Interventional Oncology Series: Lung Cancer Session. RSNA 2011, Chicago, IL, November 28, 2011.
  • Franceschi D, Matthews R, Relan N, Safaie E, and Weiss T. “Thyroid Stunning as Effect of Radioiodine Ablation Therapy.” Annual Congress of the European Association of Nuclear Medicine, Milan, Italy, October 17-31, 2012.
  • Moore WH, Freidberg E, Matthews R, Bilfinger T, and Bishawi M. “FDG-PET Imaging in Patients with Carcinoid Tumor of the Lung.” RSNA 2012, Chicago IL, November 25-30, 2012.
  • Vu CC, Muath B, Matthews R, Franceschi D, Bilfinger TV, and Moore WH. “The Predictive Value of SUVmax on 18F-FDG PET in Early-Stage Non-Small Cell Lung Carcinoma.” Society of Nuclear Medicine 2013 Mid-Winter Meeting, New Orleans LA, January 24-27, 2013.
  • Chaudhry AA, Matthews R, and Franceschi D. “Pearls and Pitfalls of I-123 Ioflupane (DATscan) SPECT Imaging: What the Radiologist and Clinician Need to Know.” ASNR 51st Annual Meeting, San Diego CA, May 18-23, 2013.
  • Chaudhry AA, Gul, M, Zawin M, Franceschi D, and Matthews R  “Pattern of Benign and Malignant Uptake within the Abdomen and Pelvis on FDG Positron Emission Tomography-Computed Tomography.” SNMMI 2013 Annual Meeting at the Vancouver Convention Centre, Vancouver, BC, Canada, June 8-12, 2013.
  • Chaudhry AA, Gul, M, Franceschi D, and Matthews R. “Pearls and Pitfalls of I-123 Ioflupane (DATscan) SPECT imaging.” SNMMI 2013 Annual Meeting at the Vancouver Convention Centre, Vancouver, BC, Canada, June 8-12, 2013.
  • Chaudhry AA, Gul M, Zawin, M, and Matthews R. “Pearls and Pitfalls of Abdominopelvic Octreotide Imaging: What the Radiologist and Clinician Need to Know.” SNMMI 2013 Annual Meeting at the Vancouver Convention Centre, Vancouver, BC, Canada, June 8-12, 2013.
  • Matthews R, LoGiurato B, Safaie E, Moore WH, Bilfinger T, Relan N, and Franceschi D. “FDG PET-CT: Patterns and Imaging Features Following Percutaneous Cryoablation Treatment for Primary Non-Small Cell Lung Cancer.” RSNA 2013, Chicago, IL, December 1-6, 2013.